Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0636
D

Inaccurate MDS Assessment for Antipsychotic Medication Use

Blackwell, Oklahoma Survey Completed on 04-04-2025

Penalty

36 days payment denial
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure the accuracy of a comprehensive assessment for one resident, as required by policy. Specifically, the annual Minimum Data Set (MDS) assessment for the resident contained conflicting information in Section N, indicating both that the resident was and was not receiving antipsychotic medications. Review of the resident's medication administration record (MAR) confirmed that the resident had been administered the antipsychotic medication Latuda during the week prior to the assessment. Interviews with the Corporate Vice President and the Director of Nursing (DON) confirmed the inconsistency in the MDS and acknowledged that the resident was indeed taking an antipsychotic at the time of the assessment. The DON stated that while the Corporate VP spot-checked the MDS coordinator's work, they themselves did not review each assessment, and the MDS was found to be inaccurate.

An unhandled error has occurred. Reload 🗙